Volume 20, Number 5—May 2014
Human Papillomavirus Prevalence in Oropharyngeal Cancer before Vaccine Introduction, United States
|Variable||OR (95% CI)†||p value|
|Asian/Pacific Islander||8.43 (2.51–28.29)||–|
|Non-Hispanic White||4.34 (1.17–97.47)||–|
*HPV, human papillomavirus; OR, odds ratio; Ref, reference group.
†Odds ratio adjusted for race and ethnicity; age was not significant.
1Members of HPV Typing of Cancers Workgroup who contributed to this study are listed at the end of this article.
- Page created: April 16, 2014
- Page last updated: April 16, 2014
- Page last reviewed: April 16, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)